NCT00998738View on ClinicalTrials.gov

Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

January 31, 2013

Conditions
NeuropathyPainRecurrent Breast CarcinomaStage IV Breast Cancer
Interventions
DRUG

Calcium Gluconate

Given IV

DRUG

Magnesium Sulfate

Given IV

OTHER

Placebo

Given IV

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

DRUG

Ixabepilone

Given IV

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00998738 - Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter